The study by Wang et al. also showed lower numbers of anti-HBs-positive and anti-HBc-negative patients in NHL cases, suggesting that anti-HBs without anti-HBc response may effectively control HBV replication in lymphoid cells and prevent neoplastic transformation and the development of NHL [24]. The gene discussed is KRT88P; the disease is non-Hodgkin lymphoma.